New Zealand - English - Ministry for Primary Industries

robyn bates pharmaceuticals - ivermectin; praziquantel - ivermectin 18.7 g/kg; praziquantel 140 g/kg - endoparasiticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

arkolette pty ltd - ivermectin; praziquantel - oral paste - ivermectin anthelmintic active 18.7 mg/g; praziquantel anthelmintic active 140.0 mg/g - parasiticides - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - ascarid - parasacris equorium | bots - gasterophilus spp. | cutaneous onchocerciasis | intestinal threadworm - s. westeri | large mouth stomach worm | large strongyles | lungworm - dictyocaulus arnfieldi | neck threadworm | pinworm - oxyuris equi | small strongyles | stomach hair worm | summer sores | tapeworm - adult/immature/heads/segments | anoplocephala magna | anoplocephala perfoliata | bot fly | bot fly - oral and gastric sta | coronocyclus spp. | craterostomum acuticaudatum | cutaneous larvae | cutaneous onchocerciasis | cyalocephalus spp. | cyathostomum spp. | cylicocyclus spp. | cylicodontophorus spp. | cylicostephanus spp. | cyliocostephanus spp. | cyliocyclus spp. | gasterophilus haemorrhoidalis | gasterophilus inermis | gasterophilus intestinalis | gasterophilus nasalis | gasterophilus pecorum | gyalocephalus spp. | paranoplocephala mammillana | parapoteriostomum spp. | petrovinema spp. | poteriostomum spp. | stomach bot | strongylus edentatus | strongylus equinus | strongylus vulgaris | summer so

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

km vet pharm sdn bhd - praziquantel; pyrantel pamoate; febantel -

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

praziquantel usp 50mg,pyrantel pamoate usp 144mg,febantel 150mg

Philippines - English - FDA (Food And Drug Administration)

plaridel products and services, inc. - praziquantel , pyrantel embonate , febantel (vet.) - tablet - 50mg/ 144mg/ 150mg

Philippines - English - FDA (Food And Drug Administration)

sannovex pharmaceutical distributor; distributor: sannovex pharmaceutical distributor - ceftazidime - powder for injection (im/iv) - 1g

Kenya - English - Pharmacy and Poisons Board

imatinib (as mesylate) - film-coated tablet - imatinib 100 mg (as mesylate) - imatinib

Kenya - English - Pharmacy and Poisons Board

imatinib (as mesylate) - film-coated tablet - 400mg - imatinib

European Union - English - EMA (European Medicines Agency)

bayer ag - riociguat - hypertension, pulmonary - antihypertensives for pulmonary arterial hypertension - chronic thromboembolic pulmonary hypertension (cteph) adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah) adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. efficacy has been shown in a pah population including aetiologies of idiopathic or heritable pah or pah associated with connective tissue disease.

European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - docetaxel - head and neck neoplasms, carcinoma, non-small-cell lung, adenocarcinoma, prostatic neoplasms, breast neoplasms - antineoplastic agents, - breast cancerdocetaxel accord in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:operable node-positive breast cancer;operable node-negative breast cancer.for patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer.docetaxel accord in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.docetaxel accord monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.docetaxel accord in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer w